Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
In Vivo Imaging for Assessing Receptor Status in Breast Cancer.
Journal: Radiology
Published: August 05, 2025
Timing of exercise therapy when initiating adjuvant chemotherapy for breast cancer: a randomized trial.
Journal: European heart journal
Published: October 31, 2022
Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer.
Journal: Clinical breast cancer
Published: December 19, 2017
Oncologist use and perception of large panel next-generation tumor sequencing.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 16, 2017
A phase I trial of ganetespib in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 (HER2)-positive metastatic breast cancer.
Journal: Breast cancer research : BCR
Published: January 18, 2017
Phase II study of paclitaxel given once per week along with trastuzumab and pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 31, 2014
A phase II open-label study of ganetespib, a novel heat shock protein 90 inhibitor for patients with metastatic breast cancer.
Journal: Clinical breast cancer
Published: September 13, 2013
Breast implant foreign body reaction mimicking breast cancer recurrence on FDG PET/CT.
Journal: Clinical nuclear medicine
Published: May 04, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026